plumbagin has been researched along with Cancer of Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Cao, YY; Chen, Q; Hao, JJ; Liu, TT; Lu, WH; Shi, F; Wang, MR; Yang, KX; Yang, LY; Yu, J; Zhang, Y | 1 |
| Cao, Y; Jia, Y; Liu, B; Shang, M; Wu, S; Yin, X | 1 |
2 other study(ies) available for plumbagin and Cancer of Esophagus
| Article | Year |
|---|---|
Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Topics: Animals; Apoptosis; Carcinogenesis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Mice, Nude; Naphthoquinones; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2018 |
Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase; Humans; Mice; Naphthoquinones; Resting Phase, Cell Cycle; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2018 |